AU661728B2 - Reagent compositions and their use in sphering cells - Google Patents
Reagent compositions and their use in sphering cells Download PDFInfo
- Publication number
- AU661728B2 AU661728B2 AU28166/92A AU2816692A AU661728B2 AU 661728 B2 AU661728 B2 AU 661728B2 AU 28166/92 A AU28166/92 A AU 28166/92A AU 2816692 A AU2816692 A AU 2816692A AU 661728 B2 AU661728 B2 AU 661728B2
- Authority
- AU
- Australia
- Prior art keywords
- cells
- reticulocytes
- cell
- reagent
- reagent composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 101
- 239000000203 mixture Substances 0.000 title claims abstract description 90
- 210000001995 reticulocyte Anatomy 0.000 claims abstract description 135
- 210000004027 cell Anatomy 0.000 claims abstract description 132
- 238000000034 method Methods 0.000 claims abstract description 79
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 78
- 210000004369 blood Anatomy 0.000 claims abstract description 61
- 239000008280 blood Substances 0.000 claims abstract description 61
- 239000002888 zwitterionic surfactant Substances 0.000 claims abstract description 12
- 239000000523 sample Substances 0.000 claims description 69
- 239000003795 chemical substances by application Substances 0.000 claims description 22
- 238000000684 flow cytometry Methods 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 22
- 229920002477 rna polymer Polymers 0.000 claims description 20
- 125000002091 cationic group Chemical group 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 230000003287 optical effect Effects 0.000 claims description 15
- 238000005286 illumination Methods 0.000 claims description 14
- 239000004094 surface-active agent Substances 0.000 claims description 13
- 230000003139 buffering effect Effects 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 239000000834 fixative Substances 0.000 claims description 9
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229940075468 lauramidopropyl betaine Drugs 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- -1 alkyl betaine Chemical compound 0.000 claims description 4
- 238000012512 characterization method Methods 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 239000006174 pH buffer Substances 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000052 comparative effect Effects 0.000 claims 2
- 239000012470 diluted sample Substances 0.000 claims 2
- BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 abstract description 32
- 108010054147 Hemoglobins Proteins 0.000 abstract description 32
- 238000010186 staining Methods 0.000 abstract description 19
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 description 89
- 239000000975 dye Substances 0.000 description 47
- CIYKWVNUXJDNNK-UHFFFAOYSA-N oxazine-750 Chemical compound N1=C2C3=CC=CC=C3C(NCC)=CC2=[O+]C2=C1C=C1CCCN3CCCC2=C13 CIYKWVNUXJDNNK-UHFFFAOYSA-N 0.000 description 19
- 238000001514 detection method Methods 0.000 description 14
- SQHOAFZGYFNDQX-UHFFFAOYSA-N ethyl-[7-(ethylamino)-2,8-dimethylphenothiazin-3-ylidene]azanium;chloride Chemical compound [Cl-].S1C2=CC(=[NH+]CC)C(C)=CC2=NC2=C1C=C(NCC)C(C)=C2 SQHOAFZGYFNDQX-UHFFFAOYSA-N 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 150000001450 anions Chemical class 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 210000001772 blood platelet Anatomy 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 5
- 239000013610 patient sample Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 210000003660 reticulum Anatomy 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000007430 reference method Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 3
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 3
- 239000001045 blue dye Substances 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 101100289061 Drosophila melanogaster lili gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000009652 hydrodynamic focusing Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010014173 Factor X Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100034829 Putative uncharacterized protein encoded by LINC01554 Human genes 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 101000870345 Vasconcellea cundinamarcensis Cysteine proteinase 1 Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 230000002902 bimodal effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 231100001015 blood dyscrasias Toxicity 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 238000001585 disappearance potential spectroscopy Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1402—Data analysis by thresholding or gating operations performed on the acquired signals or stored data
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1477—Multiparameters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/102499—Blood gas standard or control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/802,674 US5284771A (en) | 1991-12-05 | 1991-12-05 | Reagent compositions and their use in sphering cells |
| US802674 | 1991-12-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2816692A AU2816692A (en) | 1993-06-10 |
| AU661728B2 true AU661728B2 (en) | 1995-08-03 |
Family
ID=25184391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28166/92A Ceased AU661728B2 (en) | 1991-12-05 | 1992-11-05 | Reagent compositions and their use in sphering cells |
Country Status (12)
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585246A (en) * | 1993-02-17 | 1996-12-17 | Biometric Imaging, Inc. | Method for preparing a sample in a scan capillary for immunofluorescent interrogation |
| EP0698211B1 (en) * | 1993-05-14 | 2003-04-02 | Coulter International Corporation | Reticulocyte analyzing method and apparatus utilizing light scatter techniques |
| US5691204A (en) * | 1995-04-21 | 1997-11-25 | Abbott Laboratories | Compositions and methods for the rapid analysis of reticulocytes |
| JP3425830B2 (ja) * | 1995-10-06 | 2003-07-14 | シスメックス株式会社 | 新規化合物とその用途 |
| US5733784A (en) * | 1995-11-20 | 1998-03-31 | Abbott Laboratories | Reagent system and method for the differentiation and identification of reticulocytes |
| US5817519A (en) * | 1995-12-28 | 1998-10-06 | Bayer Corporation | Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples |
| US6025201A (en) * | 1995-12-28 | 2000-02-15 | Bayer Corporation | Highly sensitive, accurate, and precise automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples |
| TW379284B (en) * | 1996-04-12 | 2000-01-11 | Toa Medical Electronics | Agent for detecting reticulocyte |
| US5830764A (en) * | 1996-11-12 | 1998-11-03 | Bayer Corporation | Methods and reagent compositions for the determination of membrane surface area and sphericity of erythrocytes and reticulocytes for the diagnosis of red blood cell disorders |
| FR2759166B1 (fr) * | 1997-01-31 | 1999-04-23 | Abx Sa | Reactif de coloration pour la determination de cellules sanguines |
| US6114173A (en) * | 1997-04-03 | 2000-09-05 | Bayer Corporation | Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood |
| JPH10307135A (ja) * | 1997-05-02 | 1998-11-17 | Toa Medical Electronics Co Ltd | 赤血球形態異常の検出方法 |
| US6060322A (en) * | 1998-10-20 | 2000-05-09 | Coulter International Corp. | Method for identification of reticulated cells |
| US6271035B1 (en) * | 1998-10-20 | 2001-08-07 | Coulter International Corp. | Methods and compositions for rapid staining of nucleic acids in whole cells |
| US6582574B1 (en) * | 1999-03-31 | 2003-06-24 | City Of Hope | pK-matched running buffers for gel electrophoresis |
| AU775260B2 (en) * | 1999-03-31 | 2004-07-29 | Bayer Corporation | Single channel, single dilution detection method |
| US6190919B1 (en) * | 1999-04-21 | 2001-02-20 | The United States Of America As Represented By The Secretary Of The Navy | System for controlling deglycerolization of red blood cells |
| US6468732B1 (en) * | 2000-04-04 | 2002-10-22 | Bayer Corporation | Method and long-term stable bicarbonate-containing diluent composition, and storage means therefor, for reducing or reversing aeration induced cell shrinkage and storage induced cell swelling of a whole blood sample |
| US6368864B1 (en) | 2000-05-05 | 2002-04-09 | Coulter International Corp. | Dyes and methods of reticulocyte enumeration |
| US6784981B1 (en) * | 2000-06-02 | 2004-08-31 | Idexx Laboratories, Inc. | Flow cytometry-based hematology system |
| DE60234821D1 (de) * | 2001-03-09 | 2010-02-04 | Mitsubishi Chem Medience Corp | Messverfahren für vollblut |
| US6630990B2 (en) | 2001-06-05 | 2003-10-07 | Abbott Laboratories | Optical method and apparatus for red blood cell differentiation on a cell-by-cell basis, and simultaneous analysis of white blood cell differentiation |
| CA2428740A1 (en) | 2002-05-20 | 2003-11-20 | Bayer Corporation | Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid (csf) |
| DE102004006182B4 (de) * | 2003-08-19 | 2007-08-16 | Biotronix Gmbh | Verfahren zur elektrooptischen Analyse von Zellsuspensionen |
| US7674598B2 (en) * | 2004-05-21 | 2010-03-09 | Beckman Coulter, Inc. | Method for a fully automated monoclonal antibody-based extended differential |
| US7625712B2 (en) | 2004-05-21 | 2009-12-01 | Beckman Coulter, Inc. | Method for a fully automated monoclonal antibody-based extended differential |
| FR2883971B1 (fr) * | 2005-03-31 | 2007-11-16 | C2 Diagnostics Sa | Dispositif optique d'analyse sanguine, appareil d'analyse equipe d'un tel dispositif |
| JP2007147476A (ja) * | 2005-11-29 | 2007-06-14 | Nidec Sankyo Corp | 光散乱式粒子計数装置 |
| CN101349644B (zh) * | 2007-07-20 | 2012-06-27 | 深圳迈瑞生物医疗电子股份有限公司 | 一种白细胞分类试剂和其使用方法 |
| US8102161B2 (en) * | 2007-09-25 | 2012-01-24 | Tdk Corporation | Stable output in a switching power supply by smoothing the output of the secondary coil |
| JP2011502264A (ja) * | 2007-10-29 | 2011-01-20 | ベックマン コールター， インコーポレイテッド | 血小板集団の迅速な抗体ベースの分析のための方法 |
| US8159670B2 (en) * | 2007-11-05 | 2012-04-17 | Abbott Laboratories | Method and apparatus for rapidly counting and identifying biological particles in a flow stream |
| CN105440725A (zh) * | 2008-01-04 | 2016-03-30 | 深圳迈瑞生物医疗电子股份有限公司 | 不对称菁类荧光染料，组合物及在生物样品染色中的用途 |
| US20090314510A1 (en) * | 2008-01-11 | 2009-12-24 | Kukowski Thomas R | Elastomeric Conductors and Shields |
| US8081303B2 (en) * | 2008-03-21 | 2011-12-20 | Abbott Point Of Care, Inc. | Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching |
| CN102016686B (zh) | 2008-03-21 | 2015-03-25 | 艾博特健康公司 | 确定对生物样本成像的成像装置的焦点位置的方法和设备 |
| EP2554987B1 (en) * | 2008-03-21 | 2014-04-16 | Abbott Point Of Care, Inc. | Method and apparatus for determining red blood cell indices of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells |
| US7929121B2 (en) * | 2008-03-21 | 2011-04-19 | Abbott Point Of Care, Inc. | Method and apparatus for detecting and counting platelets individually and in aggregate clumps |
| CA2718992C (en) | 2008-03-21 | 2013-04-30 | Abbott Point Of Care, Inc. | Method and apparatus for determining the hematocrit of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells |
| CA2720068C (en) | 2008-04-02 | 2013-11-19 | Abbott Point Of Care, Inc. | Virtual separation of bound and free label in a ligand assay for performing immunoassays of biological fluids, including whole blood |
| JP5539314B2 (ja) * | 2008-04-09 | 2014-07-02 | アボット ポイント オブ ケア インコーポレイテッド | 薄厚チャンバに含まれる薄膜状体液試料中の極めて低レベルの分析物を検出する方法 |
| ES2597927T3 (es) * | 2008-04-09 | 2017-01-24 | Abbott Point Of Care, Inc. | Procedimiento para medir el área de una muestra dispuesta dentro de una cámara de análisis |
| CN101602762B (zh) * | 2008-06-10 | 2013-10-16 | 深圳迈瑞生物医疗电子股份有限公司 | 不对称菁类化合物、其制备方法及应用 |
| CN101726579B (zh) * | 2008-10-17 | 2014-06-18 | 深圳迈瑞生物医疗电子股份有限公司 | 血液检测试剂和方法 |
| CN101750274B (zh) * | 2008-12-17 | 2014-06-25 | 深圳迈瑞生物医疗电子股份有限公司 | 白细胞分类计数试剂、试剂盒以及白细胞分类计数的方法 |
| JP4969596B2 (ja) * | 2009-02-04 | 2012-07-04 | シスメックス株式会社 | 試料分析装置、試料分析方法およびプログラム |
| US20100255605A1 (en) * | 2009-04-02 | 2010-10-07 | Abbott Point Of Care, Inc. | Method and device for transferring biologic fluid samples |
| WO2010126838A1 (en) | 2009-04-27 | 2010-11-04 | Abbott Laboratories | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
| CN101988082B (zh) * | 2009-07-31 | 2015-04-08 | 深圳迈瑞生物医疗电子股份有限公司 | 白细胞分类计数试剂、试剂盒及其制备方法和白细胞分类计数的方法 |
| ES2438841T3 (es) * | 2009-12-31 | 2014-01-20 | Abbott Point Of Care, Inc. | Método y aparato para determinar el volumen celular medio de los glóbulos rojos en la sangre |
| US8906308B2 (en) | 2010-01-15 | 2014-12-09 | Abbott Laboratories | Method for determining volume and hemoglobin content of individual red blood cells |
| WO2011116305A1 (en) | 2010-03-18 | 2011-09-22 | Abbott Point Of Care, Inc. | Method and apparatus for optically determining at least one hemoglobin related parameter of a whole blood sample |
| DE102011003101B4 (de) * | 2010-12-23 | 2016-04-07 | Siemens Healthcare Diagnostics Products Gmbh | Verfahren zum Nachweis einer Plasmodieninfektion |
| EP3112863B1 (en) * | 2014-02-28 | 2019-07-17 | Sysmex Corporation | Method for detecting casts and erythrocytes in urine samples |
| CN105334191B (zh) * | 2014-07-25 | 2020-09-08 | 深圳迈瑞生物医疗电子股份有限公司 | 单个红细胞的血红蛋白浓度、体积修正方法及装置 |
| EP3268737A4 (en) | 2015-03-10 | 2018-11-14 | Alentic Microscience Inc. | Sample processing improvements for quantitative microscopy |
| US9863864B2 (en) | 2015-09-15 | 2018-01-09 | Bio-Rad Technologies, Inc. | Threshold selector for flow cytometer |
| FR3073047B1 (fr) | 2017-11-02 | 2021-01-29 | Commissariat Energie Atomique | Procede optique d'estimation d'un volume representatif de particules presentes dans un echantillon |
| CN115901581A (zh) | 2018-03-30 | 2023-04-04 | Idexx实验室公司 | 流式细胞仪的激光光学组件 |
| CN113508286A (zh) * | 2019-03-21 | 2021-10-15 | 贝克顿·迪金森公司 | 光检测系统及其使用方法 |
| ES2991130T3 (es) | 2020-06-17 | 2024-12-03 | Idexx Lab Inc | Citómetro de flujo y conjunto de óptica láser del mismo |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4412004A (en) * | 1981-06-26 | 1983-10-25 | Technicon Instruments Corporation | Method for treating red blood cells to effect sphering and reagent therefor |
| US4981803A (en) * | 1987-07-31 | 1991-01-01 | Toa Medical Electronics Co., Ltd. | Reagent for reticulocyte counting by flow cytometry |
| EP0430719A2 (en) * | 1989-12-01 | 1991-06-05 | Bayer Corporation | Compounds and reagents for determination of reticulocytes |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3684377A (en) * | 1970-07-13 | 1972-08-15 | Bio Physics Systems Inc | Method for analysis of blood by optical analysis of living cells |
| US3883247A (en) * | 1973-10-30 | 1975-05-13 | Bio Physics Systems Inc | Method for fluorescence analysis of white blood cells |
| US4346018A (en) * | 1980-06-16 | 1982-08-24 | Coulter Electronics, Inc. | Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes |
| US4336029A (en) * | 1980-08-15 | 1982-06-22 | Ortho Diagnostic Systems Inc. | Method and reagents for quantitative determination of reticulocytes and platelets in whole blood |
| US4325706A (en) * | 1980-08-15 | 1982-04-20 | Ortho Diagnostic Systems Inc. | Automated detection of platelets and reticulocytes in whole blood |
| US4490353A (en) * | 1983-07-13 | 1984-12-25 | Colgate-Palmolive Company | Antiplaque dentifrice with improved fluoride stability |
| US4735504A (en) * | 1983-10-31 | 1988-04-05 | Technicon Instruments Corporation | Method and apparatus for determining the volume & index of refraction of particles |
| US4575490A (en) * | 1984-02-29 | 1986-03-11 | Technicon Instruments Corporation | One step method for sphering and fixing whole blood erythrocytes |
| JPS61502280A (ja) * | 1984-05-31 | 1986-10-09 | ク−ルタ−・エレクトロニクス・インコ−ポレ−テッド | 白血球のクラスおよびサブクラスの同定、計数並びに試験方法およびそれに用いる試薬系 |
| US4652517A (en) * | 1984-06-11 | 1987-03-24 | Diagnostic Research Limited Partnership | Methods for the in vitro detection and identification of unknown pathogens or genetic entities |
| JPS6179163A (ja) * | 1984-09-26 | 1986-04-22 | Toa Medical Electronics Co Ltd | 血球測定用試薬 |
| JPS61280565A (ja) * | 1985-06-06 | 1986-12-11 | Toa Medical Electronics Co Ltd | フロ−サイトメトリ−用網状血球測定試薬 |
| US4707451A (en) * | 1985-09-18 | 1987-11-17 | Becton, Dickinson And Company | Detection of reticulocytes |
| US4883867A (en) * | 1985-11-01 | 1989-11-28 | Becton, Dickinson And Company | Detection of reticulocytes, RNA or DNA |
| US5039613A (en) * | 1986-11-27 | 1991-08-13 | Toa Medical Electronics Co., Ltd. | Reagents used in a method of classifying leukocytes by flow cytometry |
| US4853338A (en) * | 1987-05-20 | 1989-08-01 | Technicon Instruments Corporation | Cyanide-free hemoglobin reagent |
| JPH0746102B2 (ja) * | 1987-07-31 | 1995-05-17 | 東亜医用電子株式会社 | フロ−サイトメトリ用網状赤血球測定試薬 |
| US5242832A (en) * | 1990-03-01 | 1993-09-07 | Toa Medical Electronics Co., Ltd. | Reagent for measurement of leukocytes and hemoglobin in blood |
-
1991
- 1991-12-05 US US07/802,674 patent/US5284771A/en not_active Expired - Lifetime
-
1992
- 1992-09-04 IL IL103056A patent/IL103056A/xx not_active IP Right Cessation
- 1992-09-09 CA CA002077790A patent/CA2077790C/en not_active Expired - Fee Related
- 1992-11-05 AU AU28166/92A patent/AU661728B2/en not_active Ceased
- 1992-11-27 DK DK92120307.1T patent/DK0545313T3/da active
- 1992-11-27 DE DE69221086T patent/DE69221086T2/de not_active Expired - Lifetime
- 1992-11-27 EP EP92120307A patent/EP0545313B1/en not_active Expired - Lifetime
- 1992-11-27 AT AT92120307T patent/ATE155887T1/de not_active IP Right Cessation
- 1992-11-27 ES ES92120307T patent/ES2104802T3/es not_active Expired - Lifetime
- 1992-12-03 KR KR1019920023172A patent/KR100276145B1/ko not_active Expired - Fee Related
- 1992-12-04 JP JP4350138A patent/JP2711786B2/ja not_active Expired - Lifetime
-
1993
- 1993-04-20 TW TW082103031A patent/TW265412B/zh active
-
1994
- 1994-12-22 US US08/362,744 patent/US5633167A/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4412004A (en) * | 1981-06-26 | 1983-10-25 | Technicon Instruments Corporation | Method for treating red blood cells to effect sphering and reagent therefor |
| US4981803A (en) * | 1987-07-31 | 1991-01-01 | Toa Medical Electronics Co., Ltd. | Reagent for reticulocyte counting by flow cytometry |
| EP0430719A2 (en) * | 1989-12-01 | 1991-06-05 | Bayer Corporation | Compounds and reagents for determination of reticulocytes |
Also Published As
| Publication number | Publication date |
|---|---|
| US5633167A (en) | 1997-05-27 |
| EP0545313B1 (en) | 1997-07-23 |
| US5284771A (en) | 1994-02-08 |
| ATE155887T1 (de) | 1997-08-15 |
| DE69221086D1 (de) | 1997-09-04 |
| JPH06180316A (ja) | 1994-06-28 |
| JP2711786B2 (ja) | 1998-02-10 |
| CA2077790A1 (en) | 1993-06-06 |
| CA2077790C (en) | 2002-07-02 |
| EP0545313A1 (en) | 1993-06-09 |
| DK0545313T3 (da) | 1998-02-16 |
| DE69221086T2 (de) | 1997-11-13 |
| KR100276145B1 (ko) | 2000-12-15 |
| IL103056A (en) | 1997-04-15 |
| IL103056A0 (en) | 1993-02-21 |
| ES2104802T3 (es) | 1997-10-16 |
| AU2816692A (en) | 1993-06-10 |
| TW265412B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1995-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU661728B2 (en) | Reagent compositions and their use in sphering cells | |
| EP0545314B1 (en) | Reagent compositions and their use in the identification and characterization of reticulocytes in whole blood | |
| US5360739A (en) | Methods for the identification and characterization of reticulocytes in whole blood | |
| US6114173A (en) | Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood | |
| US4882284A (en) | Method for quantitating and differentiating white blood cells | |
| AU775260B2 (en) | Single channel, single dilution detection method | |
| US4336029A (en) | Method and reagents for quantitative determination of reticulocytes and platelets in whole blood | |
| US5773299A (en) | Methods for the rapid analysis of the reticulocytes | |
| CA2191096A1 (en) | Detection of reticulocytes | |
| CN1323395A (zh) | 鉴别网状细胞的试剂组合物和方法 | |
| MXPA96005787A (es) | Deteccion de reticulocitos |